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a b s t r a c t
Extraocular muscles (EOMs) are highly specialized skeletal muscles that originate from the head
mesoderm and control eye movements. EOMs are uniquely spared in Duchenne muscular dystrophy
and animal models of dystrophin deﬁciency. Speciﬁc traits of myogenic progenitors may be determi-
nants of this preferential sparing, but very little is known about the myogenic cells in this muscle group.
While satellite cells (SCs) have long been recognized as the main source of myogenic cells in adult
muscle, most of the knowledge about these cells comes from the prototypic limb muscles. In this study,
we show that EOMs, regardless of their distinctive Pax3-negative lineage origin, harbor SCs that share a
common signature (Pax7þ , Ki67 , Nestin-GFPþ , Myf5nLacZþ , MyoD-positive lineage origin) with their
limb and diaphragm somite-derived counterparts, but are remarkably endowed with a high proliferative
potential as revealed in cell culture assays. Speciﬁcally, we demonstrate that in adult as well as in aging
mice, EOM SCs possess a superior expansion capacity, contributing signiﬁcantly more proliferating,
differentiating and renewal progeny than their limb and diaphragm counterparts. These robust growth
and renewal properties are maintained by EOM SCs isolated from dystrophin-null (mdx) mice, while SCs
from muscles affected by dystrophin deﬁciency (i.e., limb and diaphragm) expand poorly in vitro. EOM
SCs also retain higher performance in cell transplantation assays in which donor cells were engrafted
into host mdx limb muscle. Collectively, our study provides a comprehensive picture of EOM myogenic
progenitors, showing that while these cells share common hallmarks with the prototypic SCs in somite-
derived muscles, they distinctively feature robust growth and renewal capacities that warrant the title of
high performance myo-engines and promote consideration of their properties for developing new
approaches in cell-based therapy to combat skeletal muscle wasting.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Extraocular muscles (EOMs) comprise a group of highly specialized
skeletal muscles controlling eye movements (Demer, 2007). The EOMs
represent a unique skeletal muscle phenotype based on a range of
properties, including specialized patterns of innervation and diversity
of expressed sarcomeric myosin isoforms (Spencer and Porter, 2006).
The developmental origin of EOMs adds another distinct facet to this
muscle group. While body and limb muscles develop from the
somites, EOMs are descended from prechordal and paraxial head
mesoderm (Couly et al., 1992; Noden and Francis-West, 2006).
Accordingly, the progenitors establishing the EOM primordia are of
Pax3-negative origin, in contrast to the Pax3-positive lineage origin of
limb and body muscles (Goulding et al., 1994; Horst et al., 2006;
Tajbakhsh et al., 1997). Nevertheless, EOM development is orchestrated
by the same members of the bHLH transcription factor family (MyoD,
Myf5, MRF4, myogenin) that are involved in the speciﬁcation and
differentiation of body and limb muscles (Kassar-Duchossoy et al.,
2004; Noden and Francis-West, 2006; Sambasivan et al., 2009).
The EOMs are also distinct from other skeletal muscles in their
differential response to disease, being preferentially involved or
spared in a variety of metabolic, mitochondrial and neuromuscular
disorders (Kaminski et al., 2002; Schoser and Pongratz, 2006;
Valdez et al., 2012; Yu Wai Man et al., 2005). Especially intriguing
for muscular dystrophy research is the sparing of this muscle
group in Duchenne muscular dystrophy. EOMs remain anatomi-
cally and functionally spared even at the late stages of the disease
despite the severe pathology observed in other skeletal muscles
(Kaminski et al., 1992; Khurana et al., 1995). Likewise, EOMs are
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/developmentalbiology
Developmental Biology
http://dx.doi.org/10.1016/j.ydbio.2014.08.035
0012-1606/& 2014 Elsevier Inc. All rights reserved.
n Correspondence to: Department of Biological Structure, Health Sciences
Building, Room G520, Box 35740, University of Washington School of Medicine,
1959 NE Paciﬁc Street, Seattle, WA 98195, USA. Fax: þ1 206 543 1524.
E-mail address: reuveni@uw.edu (Z. Yablonka-Reuveni).
Developmental Biology 397 (2015) 31–44
spared in animal models of muscular dystrophy resulting from
the absence of dystrophin or other dystroglycan complex-related
proteins (Khurana et al., 1995; Porter and Karathanasis, 1998;
Porter et al., 2001). The mechanism behind EOM sparing
has remained unclear (Pacheco-Pinedo et al., 2009; Porter, 1998;
Zeiger et al., 2010), but speciﬁc properties of EOM myogenic
progenitors have been proposed as possible contributory factors
(Kallestad et al., 2011; Porter et al., 2006).
Satellite cells (SCs), Pax7þ myogenic progenitors situated
between the basal lamina and sarcolemma of the myoﬁbers,
have long been recognized as the major source of myonuclei during
muscle growth and repair (Mauro, 1961; Seale et al., 2000;
Yablonka-Reuveni, 2011). SCs are proliferative during the postnatal
growth phase, adding nuclei to the enlarging myoﬁbers (Moss and
Leblond, 1971; White et al., 2010). In adult muscles, SCs are typically
quiescent, but can be activated in response to muscle injury
(Montarras et al., 2013; Schultz et al., 1978). Depending on the
magnitude of tissue trauma, SCs may divide minimally to repair
subtle damage within individual myoﬁbers or produce a larger
progeny pool that forms new myoﬁbers in cases of overt muscle
trauma (Grounds and Yablonka-Reuveni, 1993; Hawke and Garry,
2001). In addition to generating differentiated myogenic progeny, at
least some SCs can self-renew, thereby meeting the deﬁning criteria
of bona ﬁde resident stem cells (Collins et al., 2005; Kuang et al.,
2007; Sacco et al., 2008).
Most SC studies, whether performed in vivo or with isolated
cells, have focused on the easily accessible limb muscles. Such
studies have provided signiﬁcant insights into SC molecular/
cellular signatures during growth, aging and repair (Chang and
Rudnicki, 2014; Zammit et al., 2006). Limb muscles have also been
the main focus in studies on the potential of SCs as donor cells to
alleviate muscle wasting, especially in dystrophinopathy. Despite
their myogenic aptitude, enthusiasm for using limb SC-derived
myoblasts has been weakened by their limited expandability and
engraftment outcomes (Konieczny et al., 2013; Miller et al., 1997;
Tremblay et al., 1993; Wilschut et al., 2012). This drawback may
be related to heterogeneity in limb SC “stemness” with only a
minority of cells appearing capable of both progeny production
and self-renewal (Day et al., 2010; Kuang et al., 2007). Indeed, in
mouse transplantation studies only a very small fraction of donor
SCs was able to contribute to myoﬁber formation and to enter the
satellite cell niche within the host muscle (Beauchamp et al., 1999;
Collins et al., 2005; Sacco et al., 2008). Subsequently, alternative
(non-SC) sources of donor cells for muscle therapy have been
explored (Negroni et al., 2011; Tedesco and Cossu, 2012), while
bona ﬁde SCs from non-limb muscle groups have received only
limited attention. Signiﬁcantly, insight into SCs in muscle groups
that are spared from the impact of Duchenne muscular dystrophy
could unveil new cellular and molecular players that may be
beneﬁcial for treating muscle wasting disorders.
Although the unique anatomical and physiological features of
EOMs have drawn much interest (Andrade et al., 2000; da Silva
Costa et al., 2012; Spencer and Porter, 2006; Zhou et al., 2010),
knowledge about the EOM myogenic progenitors is currently
limited. One study that has used transgenic Pax7-nGFP mice for
isolating and characterizing myogenic progenitors, placed the
Pax7þ SCs as the main myogenic population in adult EOM as in
the other muscles (Sambasivan et al., 2009). Additionally, the
isolation of a number of EOM populations (SP, MP, EECD34)
containing myogenic cells has been described (Kallestad et al.,
2011; Kallestad and McLoon, 2010; McDonald et al., 2014). Our
interest in EOM SCs originated from an earlier study where we
established EOM-derived myogenic cultures as a control for
analysis of the myogenic potential of retina pericytes (Kirillova
et al., 2007). Using our standard approach for isolating myogenic
cells (Danoviz and Yablonka-Reuveni, 2012), we observed that
EOM cultures produced numerous myogenic progeny despite the
very small initial number of cells obtained from these tiny muscles
(unpublished).
In the current study we aimed to speciﬁcally characterize EOM
SCs and their regenerative capacity. We focus on their in-situ
signature, in-vitro expansion, and in-vivo engraftment aptitude. To
identify potential unique properties of EOM SCs, most aspects
were analyzed in comparison to SCs from the limb and diaphragm
somite-derived muscles.
Materials and methods
Mice
All mice were on C57BL/6 background and from colonies we
have maintained long-term at the University of Washington.
Mice were housed in a pathogen-free facility under 12:12-h
light/dark cycle and were fed ad libitum Lab Diet 5053 (Purina
Mills). Animal care and experimental procedures were approved
by the Institutional Animal Care and Use Committee at the
University of Washington. Most studies were performed with adult
mice (4–6 month old) but as indicated in the Results, some stud-
ies were done with younger (3-week old) or older (12–24 month
old) mice, and unless otherwise noted, only males were used. The
following strains (all described in our previous studies) were used
for tissue and cell isolation: (i) Knockin heterozygous Cre males
MyoDCre [Myod1tm2.1(icre)Glh, (Kanisicak et al., 2009)], and Pax3Cre
[(Pax3tm1(cre)Joe/J, (Engleka et al., 2005)] were crossed with knockin
reporter females R26mTmG [Gt(ROSA)26Sortm4(ACTB-tdTomato,–EGFP)Luo/J,
(Muzumdar et al., 2007)] to generate F1 animals (Stuelsatz et al.,
2012; Stuelsatz et al., 2014). (ii) Transgenic, heterozygous Nestin-
GFP (Mignone et al., 2004) and MLC3F-nLacZ [MLC3F¼muscle-
speciﬁc myosin light chain 3F; AKA 3F-nlacZ-2E and Tg(Myl1-lacZ)
1Ibdml/J, (Beauchamp et al., 2000; Kelly et al., 1995)]. (iii) Myf5nLacZ,
knockin heterozygous (Tajbakhsh et al., 1996; Tajbakhsh et al.,
1997). When indicated, reporter mice were crossed to generate
double heterozygous Nestin-GFP/MLC3F-nLacZ and Nestin-GFP/
Myf5nLacZ (Day et al., 2010). (iv) Dystrophin-null mdx4cv (Chapman
et al., 1989; Im et al., 1996) were crossed with Nestin-GFP mice to
produce mdx4cv/Nestin-GFP experimental mice.
Additionally, Rag1//mdx5cv double-null mice (8–9 week old)
were used as hosts in cell transplantation studies. This dystrophin-
null strain that also lacks mature T and B cells (Mombaerts et al.,
1992) was initially developed at the Jackson Lab for studies of
Dr. Emanuela Gussoni (Boston Children's Hospital, unpublished).
Notably, the mdx4cv and mdx5cv alleles were generated by point
mutations upon mutagen-treatment of male mice (Banks et al.,
2010; Chapman et al., 1989; Im et al., 1996). These mdx “cv” strains
have been preferred by some laboratories due to the reduced
occurrence of revertants (i.e., spontaneously appearing dys-
trophinþ myoﬁbers, Lu et al., 2000) compared to the “standard”
mdx mice (spontaneous mutation) (Arpke et al., 2013; Danko et al.,
1992; Decrouy et al., 1997; Im et al., 1996; Judge et al., 2006).
Tissue harvesting
Hindlimb muscles (LIMB; consisting of tibialis anterior [TA],
extensor digitorum longus [EDL] and gastrocnemius) and whole
diaphragm (DIA; includes the costal and crural muscles and the
central tendon) were harvested according to our routine proce-
dures for cell isolation or tissue sectioning (Danoviz and Yablonka-
Reuveni, 2012; Day et al., 2007; Stuelsatz et al., 2012). For the EOM
we processed two types of preparations, one for tissue sections
and one for cell isolation as detailed in our recent publication
(Stuelsatz et al., 2014). A typical EOM preparation for histology
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comprised the EOMs, the retractor bulbi muscle (an ocular
accessory muscle involved in retracting the eye into the orbit
forcing the mouse third eyelid across the cornea), the optic nerve
and the associated periocular connective tissues, all attached to
the eyeball (LifeMap, 2013), while for cell isolation only the EOMs
were collected. In both types of EOM preparations, all 4 rectus
muscles were included in their entirety, but the 2 oblique muscles
typically tear during isolation (due to their association with the
trochlea or the orbit wall), resulting in loss of a portion of these
muscles. Tissues harvested for histology or cell culture were
kept at room temperature in PBS or DMEM solution, respectively,
for subsequent processing. The DMEM solution consists of
Dulbecco's modiﬁed Eagle's medium (high glucose, with L-gluta-
mine, 110 mg/l sodium pyruvate, and pyridoxine hydrochloride,
Hyclone) supplemented with antibiotics (50 U/ml penicillin and
50 mg/ml streptomycin, Gibco-Invitrogen) and was used through-
out the various procedures described below.
Cell isolation
For each preparation, cells were typically isolated from 2–3 mice.
Harvested tissues were dissociated according to our two established
methods that rely either on Pronase digestion (Danoviz and Yablonka-
Reuveni, 2012; Yablonka-Reuveni, 2004) or collagenase/dispase diges-
tion (Ieronimakis et al., 2010; Stuelsatz et al., 2014). When digested
with Pronase, the isolated muscles were thoroughly cleaned while
gently tearing the muscles apart into small pieces with forceps. Tissue
digestion was then carried out for 1 h at 37 1C (with gentle swirling
every 15 min) followed by vigorous trituration to release cells from
the muscle bulk. When digested with collagenase/dispase, the iso-
lated muscles were superﬁcially cleaned from fascia and associated
connective tissue, then cut into small pieces using scissors and
digested for 45 min at 37 1C with intermittent triturations every
15 min. For both tissue digestion approaches, the isolated cell sus-
pensions were ﬁltered through cell strainers (100 mm and 40 mm) and
cells were then harvested by centrifugation at 1000 g for 10 min.
Cell sorting by ﬂow cytometry
Cell pellets obtained from digested muscles were suspended in
DMEM containing 10% horse serum and 10 μM Hoechst 33342
and incubated for 30min at 37 1C, after which preparations were kept
on ice. From this point, two different protocols, detailed in our previous
publications, were used to isolate SCs by ﬂow cytometry (Day et al.,
2007; Stuelsatz et al., 2014). When working with Pronase-digested
preparations from Nestin-GFP mice, the Hoechst-labeled cells were
directly sorted based on GFP expression (Day et al., 2007). For cell
preparations harvested by collagenase/dispase, the Hoechst-labeled
cells were pelleted, resuspended in a solution of ﬂuorescent antibodies
and incubated on ice for 1 h (Stuelsatz et al., 2014). The antibody
cocktail consisted of anti-Sca1 (APC, clone D7), anti-CD31 (APC, clone
390) and anti-CD45 (PE-Cy7, clone 30-F11), all from eBioscience,
diluted in ice-cold PBS containing 0.3% bovine serum albumin (BSA,
Omnipur, fractionV; Calbiochem) to a ﬁnal concentration of 600 ng/106
cells for each antibody except for the anti-Sca1, used at 300 ng/106 cells
(Stuelsatz et al., 2014). The cells were then rinsed with and resus-
pended in ice-cold PBS-0.3%BSA before sorting. This second approach
that relies on collagenase/dispase digestion and sorting based on both
Nestin-GFP and cell surface antigen, allows measuring CD45þ cells
when desired (see Results). Additionally, removal of endothelial cells
(CD31þ), which also express the Nestin-GFP transgene (Day et al.,
2007), is achieved by the triple antigen CD31/CD45/Sca1 negative
selection, in agreement with the published signature of LIMB SCs
(Ieronimakis et al., 2010; Sacco et al., 2008). Differently, our Pro-
nase-based protocol used for muscle dissociation, minimizes the
contribution of non-myogenic cells even without cell sorting
(Danoviz and Yablonka-Reuveni, 2012; Shefer et al., 2006), yielding
pure myogenic cultures from the Nestin-GFPhigh sorted populations
(Day et al., 2007).
An Inﬂux Cell Sorter (BD Biosciences, equipped with 350, 488
and 638 nm lasers) was used and sorted cells were collected
within the G0–G1 population deﬁned based on Hoechst staining,
thereby eliminating residual cell aggregates and cellular debris.
In some experiments, we also labeled the cells with 7-amino-
actinomycin D (7AAD, 1:200; Invitrogen, added just before sorting)
for dead cell exclusion. The 7AAD analyses demonstrated that our
sorted cell fractions of interest were free of dead cells; hence,
selecting for G0–G1 cells based on Hoechst dye was sufﬁcient. Sort
gates were determined by comparing ﬂuorophore signal intensi-
ties between the unstained control and each single antibody/
ﬂuorophore control. Positive events were set to at least 10 times
the ﬂuorescence intensity of negative events. Data was acquired at
20,000–100,000 events per sample and sorted cells were collected
in standard growth medium. Post-hoc analysis and ﬂow cytometry
plots were generated using FlowJo (TreeStar).
Analysis of sorted cells in primary culture and clonal assays
Growth medium consisted of DMEM containing 20% fetal
bovine serum (FBS, Gibco-Invitrogen), 10% horse serum (HS,
Gibco-Invitrogen), and 1% chicken embryo extract prepared from
whole 10-day-old embryos (Shefer and Yablonka-Reuveni, 2005).
This growth medium supports both proliferation and differentia-
tion of cultured SCs (Shefer et al., 2006; Yablonka-Reuveni, 2004).
Tissue culture wells were coated with Matrigel diluted in DMEM
(1 mg/ml ﬁnal concentration, BD Biosciences) (Danoviz and
Yablonka-Reuveni, 2012). Cultures were incubated at 37 1C, 5%
CO2 in a humidiﬁed tissue culture incubator and growth medium
and was replaced every third day after initial plating.
Primary cultures were initiated in 24-well trays at a density of
1000 cells per well. For each preparation (per each muscle group)
3–5 wells were typically seeded for analyses. Depending on overall
cell density at the time point of interest, 10–25 arbitrary ﬁelds
were quantiﬁed per well using a 20 objective. Quantiﬁcations
were based on counting DAPI-stained cell nuclei (and when
applicable immunolabeled cells as described later).
Clones were established in 48-well trays using a seeding
density of 4 cells per well for LIMB and 2 cells per well for DIA
and EOM preparations. This clonal plating density was based on
our pilot studies that indicated a lower clonal recovery of LIMB
SCs. Following our earlier studies (Day et al., 2010; Shefer et al.,
2004), clonal cultures were left undisturbed during the initial
4 days, then individual colonies were identiﬁed and their positions
were marked to facilitate monitoring progress of each clone at
later time points. Cultures were maintained for up to 3 weeks to
monitor growth, formation of myotubes, and the emergence of
Nestin-GFP positive cells. Clone size was determined at day 10 by
counting the number of DAPI-stained nuclei in ﬁxed cultures. For
each clone, a manual cell counting of individual nuclei (in single
cells and myotubes) was performed using ImageJ software after
merging in Photoshop all low magniﬁcation images (taken with
4 objective). Alternatively, clone size was estimated according to
the size of the microscopic ﬁeld the clone occupied on days 7 and
21 (i.e. clones were categorized as small, medium, large or X-large
depending on whether the clone occupied a 20 , 10 , 4 or
several 4 objective ﬁelds, respectively).
Immunoﬂuorescence analysis of freshly isolated cells, cultured cells,
and single myoﬁbers
All of preparations were ﬁxed with paraformaldehyde (PFA,
2% ﬁnal concentration) for 10 min at room temperature, then
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permeabilized with Triton X-100, blocked with normal
goat serum, immunolabeled, DAPI stained and mounted with
Vectashield, all according to our established protocols (Danoviz
and Yablonka-Reuveni, 2012; Shefer et al., 2006). Freshly isolated
cells were obtained from Pronase digested muscles following the
method described above (except that here, muscles did not require
to be as thoroughly cleaned from connective tissues) and pellets
were resuspended in 150 μl of PBS and then deposited onto a
Superfrost Plus slides (Thermo Fisher Scientiﬁc) by cytocentrifuga-
tion (1000 rpm for 5 min, Wescor cytopro cytocentrifuge). Notably,
the use of cell preparations that were not subjected to cell sorting
allowed for a higher cell number yield, achieving optimal pelleting
during cytocentrifugation. Cultured cells were prepared by
Pronase or collagenase/dispase digestion of the muscles as
described above. EOM myoﬁbers were isolated according to our
protocol (Keire et al., 2013, Note 18d) and further processed
as in our EDL myoﬁber preparations (Keire et al., 2013; Shefer
et al., 2006).
The following primary antibodies were used: anti-Pax7 (mouse
IgG1, 1:100, bioreactor supernatant, Developmental Studies Hybri-
doma Bank [DSHB]); anti-sarcomeric myosin heavy chain (mouse
IgG2b, clone MF20, hybridoma supernatant, DSHB, 1:2); anti-Ki67
(rabbit IgG, 1:300, Abcam, ab66155). Secondary antibodies used
were all produced in goat and conjugated with AlexaFluor (Invitro-
gen, 1:1000 dilution); these included anti-mouse IgG1-568; anti-
mouse IgG2b-647; anti-rabbit IgG-568. GFP reporter detection in
preparations from Nestin-GFP mice was typically done based on
direct ﬂuorescence, alternatively, as the ﬁxation for immunostaning
can reduce the intensity of direct GFP ﬂuorescence, an anti-GFP
antibody was used if necessary for signal ampliﬁcation (rabbit IgG,
1:20,000 Abcam, ab6556, Day et al., 2010).
Analysis of tissue sections (immunoﬂuorescence, H&E staining)
Freshly harvested tissues were embedded in OCT (Tissue-Tek),
ﬂash frozen in isopentane cooled with liquid nitrogen and stored
at 80 1C until ready to be cut into 10-μm thick transverse
sections using a Leica CM1850 cryostat. Sections were placed on
Superfrost Plus slides and allowed to air dry for about 30 min
before being processed immediately or stored at 80 1C.
For Pax7/laminin double immunostaining, sections were ﬁxed for
10 min in 2% PFA and antigen retrieval (required for optimal Pax7
detection) was performed by incubating slides in a solution consist-
ing of 10 mM Tris (pH 9), 1 mM EDTA, 0.05% Tween 20 for 30 min
at 97 1C and cooling slides in the same buffer at room tempera-
ture for 10 min (adapted from He et al., 2010). Slides were
removed from retrieval buffer, allowed to air dry brieﬂy, rinsed in
Tris buffered saline (TBS) for 5 min and allowed to air dry brieﬂy
again. Sections were then blocked overnight with normal goat
serum, reacted with antibodies, counterstained with DAPI and
mounted, all following our routine immunostaining protocol
(Danoviz and Yablonka-Reuveni, 2012; Stuelsatz et al., 2014). Pri-
mary antibodies included the anti-Pax7 detailed above and an anti-
laminin (1:100; rabbit IgG; ab2034, Chemicon/Millipore). Secondary
antibodies were AlexaFluor-conjugated goat anti-rabbit IgG-568 and
goat anti-mouse IgG2a-488 (1:1000; Invitrogen).
For hematoxylin and eosin (H&E) staining, sections of unﬁxed
tissues were hydrated in water for 5 min and then stained in
Harris hematoxylin for 3–5 min. Slides were then rinsed in tap
water, dipped in Scott's bluing reagent, rinsed in tap water,
incubated in 70% ethanol for 2 min, stained in eosin Y (0.25%
solution) for 2 min, dehydrated through graded alcohols and
cleared in Xylene substitute before being mounted with Xylene
substitute mounting medium (Thermo Fisher Scientiﬁc).
X-gal staining
β-galactosidase (β-gal) activity in cells expressing lacZ reporter
was detected by X-gal staining in cultured cells or whole TA
muscles, as previously described (Day et al., 2010; Stuelsatz et al.,
2012). Cell cultures were ﬁxed in 2% PFA for 10 min at room
temperature as described above for cell culture immunostaining.
When staining cells immediately after plating, the seeded cells
were allowed to settle down for 30 min and then ﬁxed as above.
Whole TAs were cut longitudinally into 2 halves and then ﬁxed in
the same manner as the cell cultures, except that ﬁxation was
done for 15 min. Fixed specimens were incubated in X-gal staining
solution for 4–6 h or overnight, for cultured cells or whole muscle,
respectively.
SC transplantation to host TA muscles and engraftment analysis
Host mice (Rag1 //mdx5cv, 8–9 week old) were anesthetized
with isoﬂurane. Analgesic (ketoprofen) was then administrated
subcutaneously (5 mg/kg) and the site of injection was shaved and
prepped with ethanol and betadine. A small incision was made
through the skin to expose the base of the TA from the distal
tendon to mid-TA. The intramuscular injection was done with a
Hamilton syringe equipped with a 31 G needle (0.85″ length, point
style 4 at 121 bevel) entering in the lower end of the muscle and
traveling to about 3/4 up before being slowly pulled back while
releasing cells in order to disperse cells evenly along the needle
path. For each host animal, the TA from one leg was injected with
EOM donor SCs, while the TA from the contralateral leg was
injected with LIMB donor SCs (15 μl per injection). Following cell
injection the skin was closed with a surgical adhesive and a
supplemental isotonic saline solution was administrated via intra-
peritoneal injection.
Donor SCs were isolated from Pronase-digested muscles of
adult (4–5 month old) Nestin-GFP/MLC3F-nLacZ mice by GFP-
based ﬂow cytometry as described above. As the MLC3F-nLacZ
transgene produces a speciﬁc LacZ expression in myoﬁber nuclei
(Beauchamp et al., 2000; Day et al., 2010; Kirillova et al., 2007;
Zammit et al., 2006), it has been used to detect donor SC-derived
differentiated progeny in engraftment studies (Collins et al., 2005).
Freshly sorted cells were collected in PBS and their concentration
adjusted to 1000 cells per 15 μl and kept on ice until the injection.
Parallel aliquots were followed-up in primary culture conditions
(as detailed above) for quality control of the injected preparations.
Both males and females were used as host and donor mice but
sexes were always matched between the donor and the corre-
sponding host mouse.
Transplanted muscles were collected 21 days post-trans-
plantation to evaluate engraftment by X-gal staining and genomic
analysis of donor-derived cells based on levels of LacZ and GFP
genes (detailed below). For both engraftment analysis approaches,
controls with vehicle only injected TAs were also performed to
ensure reliability of detection. For the genomic analysis, DNA
from whole engrafted TA muscles was isolated using DNeasy kit
(Qiagen) and used for analyzing by PCR the level of GFP and
MLC3F-nLacZ genes (donor-derived) vs. H-ras and Cyp1A1 (con-
tributed by both host and donor cells). PCR was performed using
HotStarTaq DNA polymerase (Qiagen) in a 25 μl total volume using
10 pmol of forward and reverse primers and 2 μl or 4 μl of DNA
(100 ng/μl stock solution) per reaction for GFP and LacZ or H-ras
and Cyp1A1, respectively. The PCR program consisted of incuba-
tion at 95 1C for 10 min, followed by 28–32 cycles of 94 1C for 30 s,
62 1C for 45 s, 72 1C for 1 min, and a ﬁnal extension step at 72 1C
for 10 min. The number of ampliﬁcation cycles was 28 for H-ras
and Cyp1A1, and 32 for LacZ and GFP. PCR products were
separated on 1.5% agarose gels containing 1:10,000 dilution of
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SYBR Green I (Molecular Probes). Gels were imaged using Gel Logic
212 Pro (Carestream). Quantiﬁcation of the resulting bands for
each PCR product was done using ImageJ software. Each donor
gene product (LacZ and GFP) was ﬁrst normalized with each of the
reference gene product (Cyp1A1 and H-ras). The EOM/LIMB ratio
was then calculated for each of these normalized values. Given
that within the same mouse these ratios are comparable regard-
less of the donor or reference gene used, ﬁnal results are presented
per each mouse as the average of these ratios. Primer set
sequences (and product size):
LacZ, GCTTCATCCACCACATACAG / CGATGAGCGTGGTGGTTATG
(402 bp).
GFP, CGACGTAAACGGCCACAAG / GTAGTTGCCGTCGTCCTTG
(259 bp).
H-ras, ATGACAGAATACAAGCTTGTGGTG / GGCAAATACACAGAG-
GAAGCCCTC (459 bp, 249 bp if used for cDNA analysis) (Kastner
et al., 2000; Smith et al., 1994).
Cyp1A1, GACACAGTGATTGGCAGAGA / AACGGATCTATGGTCT-
GACC (144 bp) (Dai et al., 2009).
Microscopy and imaging
Observations were made with an inverted ﬂuorescent micro-
scope (Eclipse TE2000-S, Nikon), except for TA engraftment
studies by X-gal staining where a Nikon Stereoscopic Zoom
Microscope (SMZ1500) was used. Images were typically acquired
using CoolSNAP ES monochrome CCD camera (Photometrics)
controlled with MetaVue Imaging System (Universal Imaging
Corporation). For acquiring real color images of X-gal staining,
images were taken with a Digital Sight DS-Ri1 color camera
controlled by NIS-Elements F software (Nikon). Digitized images
were assembled using Adobe Photoshop software.
Data analysis and statistics
Graphs were generated and data were analyzed by one-way
ANOVA with Bonferroni–Holm or Tukey post-hoc analysis using
Excel with Daniel's XL Toolbox Add-In (by Daniel Kraus, Würzburg,
Germany). For all studies, unless otherwise noted, p-values of less
than 0.05 were considered to be statistically signiﬁcant and 3–5
experimental repeats were performed.
Results and discussion
Although derived from a Pax3-negative lineage, EOM myogenic
progenitors display classic SC features in common with their limb and
diaphragm counterparts
In accordance with EOM development from a Pax3-negative
lineage (Harel et al., 2009; Sambasivan et al., 2009; Stuelsatz et al.,
2014), myogenic progenitors in adult EOMs do not demonstrate
ancestral, nor current, expression of Pax3 (Fig. S1). Regardless of
this distinct linage origin, in common with all muscles examined
to date, myogenic progenitors in adult EOMs display classic SC
features based on being of MyoD-positive lineage origin
(Fig. S1; in accordance with Kanisicak et al., 2009) and expressing
Pax7 (Fig. S2; as previously reported for postnatal (P10) EOM in
Harel et al., 2009). The presence of Pax7þ SCs is evident in isolated
EOM myoﬁbers along with co-expression of the Nestin-GFP
transgene (Fig. 1A), previously reported by us as a characteristic
of SCs in LIMB and DIA (Day et al., 2007; Day et al., 2010; Fig. S1 in
Stuelsatz et al., 2012). Pax7/Nestin-GFP co-expression was addi-
tionally established in freshly isolated SC preparations from EOM,
LIMB and DIA (Fig. S2). Also, in common with SCs in all muscle
groups examined to date (Beauchamp et al., 2000; Day et al., 2010;
Ono et al., 2010; Stuelsatz et al., 2012), myogenic progenitors in
adult EOM are β-gal positive when analyzed using the Myf5nLacZ
knockin reporter mouse (Fig. S3).
Next, we have extended our approach for SC isolation from LIMB
and DIA SCs (Day et al., 2007; Day et al., 2010), and utilized the
Nestin-GFP transgene ﬂuorescence to sort EOM SCs by ﬂow
cytometry (Figs. 1 and S3). Antigen-based cell sorting further
demonstrated that the bulk of EOM SCs (Nestin-GFPhigh) are
CD31/CD45/Sca1 (Fig. S3B and G–G″0), in agreement with the
published signature of LIMB SCs (Ieronimakis et al., 2010; Sacco
et al., 2008). Our characterization of the sorted Nestin-GFPhigh cells
according to myogenic marker expression (by immunostaining) in
primary culture, shows a typical progression through proliferation,
differentiation and renewal, as summarized schematically in Fig. 1C.
During the initial days in culture (days 3–4), essentially all cells
were positive for Pax7 and MyoD, a common signature of prolifer-
ating progeny of SCs (Halevy et al., 2004; Shefer et al., 2006;
Zammit et al., 2004), followed by the appearance of differentiating,
Myogeninþ single cells, while formation of myotubes, that just had
begun at day 6, was evident throughout the culture by day 7. EOM
cultures were also monitored for the dynamics of Nestin-GFP
transgene expression. As we have previously demonstrated for
LIMB, SC proliferating progeny do not retain Nestin-GFP expression,
but once cultures increase in cell density and develop myotubes,
Nestin-GFP expression re-emerges in quiescent Pax7þ/MyoD cells
(i.e. renewal cells) (Day et al., 2007; Day et al., 2010). Likewise, in
the present EOM study, while proliferating progeny of cultured SCs
no longer exhibit Nestin-GFP ﬂuorescence, later, the transgene is re-
expressed in numerous renewal cells (i.e., Nestin-GFPþ/Pax7þ) that
appear among the myotubes (detected morphologically and by
immunostaining for sarcomeric myosin) (Figs. 1C and D and S3G–
G″0) and are distinct from the differentiating MyoDþ/Myogeninþ
single cells (Day et al., 2007). Notably, while the detection of
renewal cells in SC cultures according to the emergence of Pax7þ/
MyoD cells has been reported (Day et al., 2009; Halevy et al.,
2004; Ono et al., 2010; Shefer et al., 2006; Zammit et al., 2004), the
expression of Nestin-GFP in renewal cells provides a visual means to
monitor the dynamics of SC renewal in live cultures.
Progeny of EOM SCs outperform their LIMB and DIA counterparts in
primary culture and clonal analyses – evidence for cell intrinsic
distinctions
SCs from LIMB, DIA and EOM muscles (isolated based on
Nestin-GFP ﬂuorescence as in Figs. 1B and S3A) were plated at
the same density across muscle groups (1000 cells per well in 24-
well trays) to follow up the dynamics of cell growth, differentia-
tion and renewal (Fig. 2). Representative phase images are shown
in Fig. 2A–F and overall growth patterns based on the total number
of nuclei (DAPIþ nuclei in single cells and myotubes) are illu-
strated in Fig. 2G. For all three muscle groups, there was little if
any growth before the 3rd culture day, followed by a proliferative
phase between days 3 and 5, and formation of myotubes that
became evident throughout the cultures by day 7 along with
continuous cell expansion that was more robust in EOM cultures
as clearly discerned by culture days 10 and 14. Growth dynamics
were further investigated by double-immunostaining for Pax7
and sarcomeric myosin (MF20) together with DAPI staining
(Fig. 2H–K). While at late time points the percentage of nuclei in
differentiated (MF20þ) cells among all three muscle groups
appeared to be conserved with a value of 40% on day 10 and
50–60% on day 14 (Fig. 2K), DIA cultures persistently exhibited
an earlier onset of differentiation, already reaching their max-
imum fusion index by day 7 (Fig. 2K). The quantiﬁcation of Nestin-
GFPþ/Pax7þ cells (Fig. 2K) demonstrates a higher presence of
renewal cells in EOM cultures. This enhanced renewal could
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possibly be related to the overall increased cell density in EOM
primary cultures that, based on SC clonal analyses shown next,
appears to reﬂect an intrinsic property of individual EOM SCs.
Next, we were interested to determine if the distinct growth
and renewal dynamics of EOM primary cultures reﬂect intrinsic
properties of individual SCs. For this, SCs from the three muscle
groups, isolated as in Fig. 1B, were analyzed clonally (Fig. 3). In one
set of experiments, clone size was quantiﬁed at day 10 based on
the total number of DAPIþ nuclei in single cells and myotubes
(Fig. 3A–D). A striking distinction of the EOM clones, evident even
before cell counting, was the increased presence of larger and
denser clones as illustrated in the lower and higher magniﬁcation
images (Fig. 3A and B). The distribution of clones according to the
number of nuclei and cumulative percentile curves are depicted in
Fig. 3C. This graph clearly displays greater numbers of clones with
higher numbers of nuclei in EOM compared to LIMB and DIA. Only
EOM depict clones with more than 12,500 nuclei (6%, 5 out of 89
total clones), while at the low end, LIMB and DIA have respectively
12 (18%) and 11 (11%) clones with less than 200 nuclei, whereas
EOM has none. Descriptive statistics of the clonal data are further
summarized in a boxplot format (Fig. 3D), demonstrating a higher
median, a higher average and a higher range of “maximum
outliers” for EOM clones. Notably, whereas about 50% (44 out of
89 total) of EOM clones display more than 2900 nuclei, only 8%
(5 out of 65 total) of LIMB clones and 13% (13 out of 103 total) of
DIA clones harbor such cell number.
In a second set of clonal experiments, we monitored the extent
of renewal cells within clones, based on the re-appearance of
Nestin-GFPþ cells (Fig. 3E and F). Representative images of day 21
clones (Fig. 3E) illustrate the typical presence of a higher number of
renewal cells within EOM clones compared to LIMB and DIA clones.
Furthermore, the frequency of clones containing renewal cells was
strikingly higher in EOM preparations (Fig. 3F). At 3 weeks, renewal
cells were well pronounced in about 80% of the EOM clones while
only about 17% of the LIMB clones contained such cells. DIA clones
were not quantiﬁed here for renewal cells, but values were found
to be in the mid-range between LIMB and EOM based on a separate
study where LIMB and DIA were compared (unpublished). Note
that the appearance and quantity of renewal cells within clones
was in accordance with clone size (Fig. 3F), with both cell density
and presence of myotubes within clones being critical for the
development of renewal cells. Indeed, previous studies have noted
a relationship between density of myogenic cultures and extent of
renewal cells (Day et al., 2010; Ono et al., 2010).
We next investigated the in-vivo proliferative status of EOM
SCs compared to their LIMB and DIA counterparts. An a priori
increased activity of the EOM cells in vivo, could potentially
account for their enhanced in-vitro performance. Our pilot
histological studies of muscles from adult mice (4–6 month
old) injected with BrdU for 3 days (according to Ieronimakis
et al., 2010) only detected extremely rare proliferating cells
when examined with anti-BrdU or anti-Ki67 antibodies, while
many nuclei in the periocular glandular tissue were positive
(data not shown). This rarity of proliferating cells combined
with the paucity of SCs in adult muscles (Fig. S2A–C0), prompted
us to analyze SC proliferative status in freshly isolated cells
Fig. 1. In-situ detection, isolation and cell culture marker signature of EOM SCs from adult mice. (A) Isolated EOM myoﬁbers from adult Nestin-GFP transgenic mice
demonstrating co-expression of the SC marker Pax7 and transgenic Nestin-GFP along with DAPIþ nuclei. EOM myoﬁbers vary in their dimensions and shown images
illustrate “thick” (A1) and “narrow” (A2) specimens. Arrowheads point to examples of SCs deﬁned based on triple-labeling for Pax7, Nestin-GFP and DAPI. (B) A
representative ﬂow cytometry proﬁle of Nestin-GFPhigh cells isolated from EOM by Pronase digestion. The plot shows GFP ﬂuorescence (X-axis) vs. the side scatter parameter
(Y-axis) among all G0–G1 cells. The % value indicates the frequency of the highlighted Nestin-GFPhigh population out of the parent G0–G1 population analyzed. The side-
scatter parameter, measuring cell granularity (internal complexity, Yablonka-Reuveni, 1988), has been used here to better distinguish the SC population. Additional cell
sorting plots of SCs isolated from EOM vs. LIMB and DIA are shown in Fig. S3A and B. (C) Schematic of myogenic marker expression by EOM SCs and their progeny, showing
the typical progression through proliferation, differentiation and renewal stages in primary culture (modiﬁed from Yablonka-Reuveni, 2011). SCs were sorted as shown in
panel B and the expression of the characteristic myogenic markers was analyzed by immunostaining with commonly used antibodies (Danoviz and Yablonka-Reuveni, 2012;
Shefer et al., 2006). (D–D''') Pax7/sarcomeric myosin (MF20) immunostaining of day 14 cultures demonstrating Pax7þ renewal cells expressing the Nestin-GFP transgene and
located in between the myotubes (MF20þ). Nuclei of immunostained cultures are highlighted by DAPI counterstaining. Scale bars, 50 μm.
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released from whole muscle, which permits looking at
populations large enough for a meaningful comparison between
EOM, LIMB and DIA muscles (Fig. 4A and B). We opted here to
look at unsorted populations, allowing us to gain insight into
both the SC population (Pax7þ cells) and the non-myogenic
cells, and to obtain cell numbers high enough for effective cell
pelleting by cytocentrifugation (especially important for the
EOM with its smaller size and SC numbers). In all
three muscle groups from adult mice (4–6 month old), the
percentage of proliferating SCs (Ki67þ/Pax7þ cells out of total
Pax7þ cells) was low (0.8%, 1.5% and 0.3% for LIMB, DIA and
EOM, respectively, Fig. 4B). Although an earlier study reported
that mouse EOMs distinctively retain a pool of activated SCs in
adult life (McLoon and Wirtschafter, 2002), the proliferative
index was also relatively low (1%) and was expressed as
frequency of myoﬁbers harboring BrdUþ SCs in cross sections,
while in our current study, values were obtained in reference to
total number of Pax7þ cells. For an additional control, Pax7/Ki67
immunostaining analyses were also performed on cells disso-
ciated from muscles of juvenile mice (3-week old) in which SCs
are known to be more proliferative. While LIMB and DIA
preparations showed an increase in the frequency of proliferat-
ing SCs with younger age, only a minimal change was identiﬁed
for EOM SCs (Fig. 4B), suggesting that in-vivo proliferation of
EOM SCs ceases earlier in juvenile life. It is conceivable that the
smaller diameter of EOM myoﬁbers indeed entails a shorter
period of myoﬁber enlargement by myonuclear accretion.
Human studies have shown that EOM myoﬁbers attain maximal
diameter by 12 year of age, while limb and body muscles
reach their maximal myoﬁber diameter 20 years of age
(Grounds and Shavlakadze, 2011). Myoﬁber growth by nuclear
accretion is known to cease earlier than the subsequent growth
by cytoplasmic enlargement; e.g., in the mouse LIMB (EDL
muscle) myonuclear addition occurs until 3 weeks of age
while growth by volume continues even at 8 weeks of age
(White et al., 2010). Intriguingly, this hypothesis of an earlier
cession of EOM SC proliferation during the juvenile growth
phase could theoretically be an underlying factor for the
increased performance of EOM SCs in the in-vitro analyses
summarized above.
Collectively, we have demonstrated that adult EOMs harbor Pax7þ
SCs that are quiescent, typical to SCs in prototypic adult muscles, but
are uniquely endowed with a high proliferative potential as revealed
in cell culture assays. This comprehensive study of SC performance is
the ﬁrst to demonstrate the superiority of EOM SCs not only in
primary culture but also at the clonal level, showing a superior growth
potential and renewal capacity compared to SCs from “traditional”
muscle groups. The superiority of EOM SCs is also maintained in aging
according to our primary culture and clonal studies with cells isolated
from 22–24 month old mice (Fig. S4A–C).
EOM SCs from dystrophin-null mdx4cv mice retain performance
superiority
As detailed in Introduction, the EOMs are spared in Duchenne
muscular dystrophy and in animal models lacking dystrophin.
Fig. 2. Growth analysis of LIMB, DIA and EOM SC primary cultures. SCs were isolated from adult Nestin-GFP mice as described in Figs. 1B and S3A and plated at 1000 cells per
well in 24-well plates. (A–F) Representative phase images of day 5 and day 9 cultures. (G) The number of total nuclei per microscopic ﬁeld (20 objective) was counted
based on DAPI staining of cultures ﬁxed on days 5, 7, 10 and 14. Data are expressed as mean7SEM. Per each culture day, one-way ANOVA analysis reveals a statistical
difference (po0.01) between the three muscle groups, except for DIA vs. EOM cultures on day 5 (p¼0.36), and LIMB vs. DIA cultures on day 10 (p¼0.05) and on day 14
(p¼0.86). (H–J0) Representative ﬂuorescent images of day 10 LIMB, DIA and EOM cultures double-immunostained for Pax7 and sarcomeric myosin (MF20), demonstrating
the presence of Pax7þ/Nestin-GFPþ renewal cells. (K) Quantiﬁcation of differentiated and renewal cells on days 7, 10 and 14 of LIMB, DIA and EOM cultures immunostained
for Pax7 and sarcomeric myosin (MF20). Scale bars, 100 μm (A–F) and (H–J0).
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The status of SCs in EOMs from dystrophin-null models however,
has been scarcely investigated. Although comparisons of EOM vs.
LIMB CD34þ populations from mdx mice were published, these
studies only focused on relative proportions of freshly sorted cells,
but did not analyze the myogenic nature/performance of these
populations (Hebert et al., 2013; Kallestad et al., 2011). The
prevailing view that SC proliferative potential is exhausted over
time in Duchenne muscular dystrophy (due to ongoing demand
for SC contribution during the repeated rounds of myoﬁber
degeneration and regeneration, Webster and Blau, 1990) would
suggest that EOM SCs are not affected in the dystrophin-null
muscle as they are not exposed to ongoing regenerative demand in
the in-vivo state. If dystrophin is however required for actual SC
performance, once the EOM SCs from dystrophin-null muscles are
Fig. 3. Clonal analysis of LIMB, DIA and EOM SCs. SCs were isolated from adult Nestin-GFP mice as described in Figs. 1B and S3A. (A–D) Clonal cultures were ﬁxed on day 10
and stained with DAPI for quantifying clone size according to the number of nuclei. (A and B) Examples of (A) low-magniﬁcation whole clone images (DAPI stained), and
(B) high-magniﬁcation phase images demonstrating the typical morphology and cell density of average size LIMB, DIA and EOM clones. (C) Distribution of LIMB, DIA and
EOM clones according to the number of nuclei per clone. Clones are clustered in bins in ascending order according to the number of nuclei per clone (x-axis) vs. the
percentage of clones in each bin out of total clones analyzed (histograms, left y-axis). In the cumulative curves, each data point (round-shaped, right y-axis) shows the
percentage of clones out of total clones analyzed that contain less than, or equal to (r) the corresponding number of nuclei per clone size range indicated on the x-axis bins.
(D) Clonal data analyzed in (C) are also illustrated as boxplots, depicting the quartile distribution, mean (black crosses) and outliers (red circles, right y-axis) for the number
of nuclei per clone; whisker ranges and outliers were calculated as previously detailed by us in (Shefer et al., 2013). Asterisk denotes statistically signiﬁcant difference in
clone size between EOM vs. LIMB and DIA clones (po0.01). (E) Representative phase and ﬂuorescence images of day 21 clones established from LIMB, DIA and EOM SCs
showing Nestin-GFPþ renewal cells with a typical higher manifestation in EOM clones. (F) Quantiﬁcation of SC clones that harbor Nestin-GFPþ cells demonstrates that
renewal cells are consistently more frequent in EOM clones. The relative clone size was also estimated by categorizing each clone as small, medium, large or X-large
depending on whether the clone occupied a 20 , 10 , 4 or several 4 objective ﬁelds, respectively. On day 7, only EOM cultures displayed clones in the “Large” category.
Then, by day 21, solely EOM harbored “X-Large” clones, while clones falling in the two smaller categories represented only 30% of total clones for EOM vs. 60% for LIMB
cultures. Scale bars, 1 mm (A), 250 μm (B), 50 μm (E).
P. Stuelsatz et al. / Developmental Biology 397 (2015) 31–4438
prompted to enter a regenerative activity, they may exhibit a
declining performance compared to wildtype EOM SCs.
To bypass the distinctive in-vivo milieu of the cells in affected
(LIMB and DIA) or unaffected (EOM) environments of dystrophin-
null muscles we again compared SCs in culture, using the mdx4cv
mice as the source for dystrophin-null SCs. Fig. 5 depicts images of
H&E stained muscle sections from LIMB, DIA and EOM of adult
mdx4cv mice. The series of histological images illustrates that
while LIMB and DIA display typical signs of muscle pathology
associated with the absence of dystrophin (central myonuclei, split
myoﬁbers and ﬁbrosis, with the latter more pronounced in DIA),
EOM show no such pathology. Noticeably, the retractor bulbi (RB),
an ocular accessory muscle, although residing adjacent to the
EOM (Fig. 5E) and of the same Pax3-negative embryonic origin
(Stuelsatz et al., 2014), is affected by dystrophin absence as
demonstrated by the extensive presence of central myonuclei
similar to LIMB (Fig. 5A). EOM sparing vs. RB pathology is in
accord with earlier ﬁndings in the “standard” mdx mouse
(Andrade et al., 2000; Marques et al., 2007).
To enable sorting of SCs from mdx4cv muscles, we generated a
colony of mdx4cv/Nestin-GFP mice. We ﬁrst conﬁrmed that the
agreement between Pax7 and Nestin-GFP was retained in the
dystrophin-null mouse (Fig. S5A–D″). In this set of experiments,
the inclusion of antigen-based sorting (Fig. S3B) has enabled us to
assay the frequency of CD45þ hematopoietic cells (Fischer et al.,
1991), which are involved in inﬂammatory and ﬁbrosis processes
that occur in mdx pathology (Fischer et al., 1991; Morrison et al.,
2000; Spencer et al., 2001; Villalta et al., 2009). As done above
with wildtype cultures, myogenic homogeneity of the sorted
populations was validated according to myogenic marker expres-
sion by antibody staining of the resulting primary cultures (data
not shown). To analyze SC performance, primary and clonal
cultures of sorted SCs (mdx4cv vs. wildtype) were initiated at
1000 cells per well of 24-well trays or as 2–4 cells in 48-well trays,
respectively, in the same manner as in Figs. 2 and 3.
Collectively, the comparison between mdx4cv and wildtype
adult mice yielded the following key observations (Fig. 6): (i) In
accordance with the muscle histopathology evidence (Fig. 5), the
frequency of CD45þ cells (out of G0-G1 cells) increased signiﬁ-
cantly (po0.03) in mdx4cv LIMB and DIA (Fig. 6D). In mdx4cv EOM
preparations, there was only a trend (but not a statistical differ-
ence, p¼0.06) of CD45þ cell increase that could likely be
explained by the overall increase in inﬂammatory cell production
shown for mdx mice (Lagrota-Candido et al., 2002). Conversely,
there was a decline in SC frequency in LIMB and DIA (po0.03)
isolated preparations from mdx4cv mice, while EOM preparations
were unaffected (p¼0.09) when examining sorted populations
(Fig. 6D). (ii) Primary cultures from LIMB and DIA of mdx4cv mice
demonstrated only a meager growth (and no appearance of
Nestin-GFPþ renewal cells), while mdx4cv EOM cultures retained
robust growth and renewal (Fig. 6A and B). In our additional
studies of LIMB cultures from juvenile mdx4cv mice, SC growth
impairment was ﬁrst observed after 6 weeks of age, while cultures
appeared normal beforehand. (iii) Clonal assays of SCs further
Fig. 4. Assessment of in-vivo proliferative activity of SCs. Unsorted cell prepara-
tions obtained after Pronase digestion of LIMB, DIA and EOM of adult (4–6 month
old) and juvenile (3-weeks old) mice were subjected to cytocentrifugation,
followed by Pax7/Ki67 double immunostaining combined with DAPI counter-
staining. (A) Image shown is of a preparation from LIMB of juvenile mice, which
contains the highest number of Ki67+/Pax7+ double-labeled cells. (B) SCs were
identiﬁed based on Pax7 immunostaining and their proliferative activity was
determined by calculating the percent of cells double-immunolabelled for Pax7
and Ki67 (Ki67þ/Pax7þ cells) out of all Pax7þ cells. Preparations of spleen cells
were used as a highly proliferative control for Ki67 immunolabeling (Ki67þ cells:
48.1% out of 7998 and 18.0% out of 4324 total nuclei, in juvenile and adult mice,
respectively); these cells were also found negative for Pax7. Scale bar, 50 μm.
Fig. 5. H&E stained cross sections of tissue preparations from mdx4cv mice. (A) TA,
(B) DIA, and (C–F) periocular tissues from 1 year old mice. (C) Schematic of a
periocular tissue preparation that comprises the EOMs, the retractor bulbi (RB) and
the optic nerve (OptN), harvested together with the eyeball. The black dotted line
indicates the level of the sections shown in: (D) periocular tissue (low magniﬁca-
tion), (E) RB and (F) EOM (high magniﬁcation). Scale bars, 50 μm (A and B) and
(E and F), 200 μm (D).
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demonstrated the inability of individual SCs frommdx4cv LIMB and
DIA preparations to establish clones (according to clone number
and size), while EOM clones retained robust growth when
prepared from mdx4cv mice (Fig. 6C and D). Noticeably, a severely
compromised myogenic growth was also observed in isolated EDL
myoﬁbers and in cultures of unsorted cell preparations from LIMB
Fig. 6. EOM SCs from dystrophin-null mdx4cv mice retain performance superiority. LIMB, DIA and EOM SCs were isolated from Nestin-GFP (wt) and mdx4cv/Nestin-GFP
(mdx) 6 month old mice by ﬂow cytometry according to Nestin-GFP expression combined with an antigen-based sorting approach (Fig. S3B), which permitted assaying the
level of CD45+ cells as a reference for the inﬂammatory process associated with dystrophinopathy. (A) For each muscle group, the number of total nuclei was counted based
on DAPI staining of cultures ﬁxed on days 3–7. Data are expressed as mean (7SEM) number of nuclei per 10 microscopic ﬁelds (20 objective) and not per single ﬁeld as in
Fig. 2G due to the low number of cells in mdx LIMB and DIA cultures. Within each muscle group, asterisks denote statistically signiﬁcant differences (po0.03, one-way
ANOVA) for wt vs. mdx cultures per each culture day; notably, there are no statistical differences between EOM wt vs. mdx at any of the culture days. (B) Representative
images of day 14 cultures of LIMB, DIA and EOM depict the meager growth of mdx cultures from LIMB and DIA SCs, while also highlighting the outperformance of EOM SCs
within the wt groups. Among the mdx cultures, only those from EOM developed Nestin-GFPþ renewal cells. Scale bar, 100 μm. (C) Clonal cultures of LIMB, DIA and EOM SCs
isolated from wt and mdx mice were quantiﬁed on day 10 in the same manner as in Fig. 3A–D. Clones are plotted individually based on total number of DAPIþ nuclei per
clone. One-way ANOVA analysis reveals a statistical difference (po0.03, asterisks) between wt and mdx clones within LIMB and DIA, but not within EOM (p¼0.13). A
statistical difference (po0.03) was also noted between EOM clones vs. LIMB and DIA regardless of mdx or wt origin. (D) Summary of additional relevant data from the
analysis of the sort proﬁles, and the primary and clonal cultures. The percentage of CD45þ cells was determined by using a distinctive ﬂuorochrome (PE-Cy7 for anti-CD45
vs. APC for anti-CD31 and anti-Sca1) when gating out the CD31þ , CD45þ , and Sca1þ cells. For all panels, asterisks denote statistically signiﬁcant differences (po0.03).
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and DIA muscles of adult mdx4cv mice (data not shown), which
argues against the possible presence of better performing myo-
genic progenitors that could have been excluded from our mdx4cv
cell culture assays summarized in Fig. 6.
The impairment of LIMB and DIA SCs from adult mdx4cv mice
that we have persistently observed in cell culture assays seems
to be in contrast with the in-vivo regenerative activity observed
in affected mdx muscles and presumed to reﬂect the presence
of performing SCs (Heslop et al., 2000; McGeachie et al., 1993;
Yokota et al., 2006). One possible explanation to this discre-
pancy could be that the residual SC activity detected in the
current LIMB and DIA cell cultures from the dystrophin-
deﬁcient mice is sufﬁcient for supporting the reported in-vivo
mdx regenerative activity. Moreover, our unpublished observa-
tion that the extent of attrition in primary cell cultures from
LIMB and DIA of mdx4cv mice was somewhat alleviated when
initiating cultures at a much higher density further supports the
possibility of a beneﬁcial “community effect”. Notably, a recent
study of mdx mice corroborates our cell culture results with
mdx4cv mice, pointing out to a decline in satellite cell activity in
older dystrophin-null mice compared to wildtype (Jiang et al.,
2014). It remains however possible that limb and body muscles
are more affected in the mdx4cv model, as this strain has a lower
number of revertants (dystrophinþ) myoﬁbers than the “stan-
dard” mdx mice (Danko et al., 1992). Indeed, while we observed
extensive abnormal morphologies (branching, internal splitting,
bifurcation) in most EDL myoﬁbers by 12–16 weeks of age in
mdx4cv mice (Fig. S5E–H; see also Banks et al., 2014 for similar
conclusions), such level of malformations was observed in
“standard” mdx mice only when reaching 26 weeks of age,
while less than 5% of the myoﬁbers displayed abnormalities by
15 weeks of age (Head et al., 1992;Williams, 1993). However, a
side by side comparison between mdx4cv, mdx and wildtype
mice, looking at SC clonal growth, myoﬁber abnormalities and
whole muscle regenerative capacity is yet to be performed.
Overall, our cell culture experiments where SCs are “freed”
from their in-vivo dystrophic context have permitted comparison
of SC populations in a common “growth promoting” environment.
Using this in-vitro approach, and especially analyzing clonal
growth of single cells, we have clearly demonstrated that SCs
from LIMB and DIA muscles perform poorly when isolated from
dystrophin-null mice, whereas SCs isolated from mdx4cv EOM
were unaffected and performed at the same level as their wildtype
counterparts. This comparable (and robust) performance of EOM
SCs from mdx4cv and wildtype mice further indicates that dystro-
phin is not essential for EOM SC activity, while the poor perfor-
mance of mdx4cv LIMB and DIA SCs could possibly be associated
with the accelerated myogenic differentiation observed previously
in primary cultures from “standard” mdx mice (Yablonka-Reuveni
and Anderson, 2006). Future studies are needed to establish the
mechanism behind the preserved or impaired performance of SCs
from the different muscle groups of dystrophin-null mice.
EOM SCs demonstrate higher engraftment efﬁciency after
intramuscular transplantation
In the studies described above we evaluated SC performance in
cell culture, thereby providing an identical environment in which to
study all SCs populations from wildtype and mdx4cv mice for LIMB,
DIA and EOM. The goal of this engraftment study was to evaluate
whether the regenerative superiority of EOM SCs revealed in cell
culture assays is maintained in vivo when SCs are again exposed
to a common environment. For this, donor SCs from EOM and
LIMB were transplanted into tibialis anterior (TA) muscles of
Rag1//mdx5cv mice. The dystrophin-null context has provided a
muscle environment that promotes SC myonuclear contribution
due to ongoing muscle repair, while the Rag1-null context mini-
mizes possible rejection of donor cells as the mutant lacks mature B
and T cells (see Materials and methods). Given the distinct lineage
origin of donor EOM SCs and host TA muscles, we ﬁrst validated
that EOM and LIMB SC progeny could fuse with each other. Using a
co-culture approach with reporter-speciﬁc marking per each line-
age, we demonstrated that progeny of EOM SCs frequently gener-
ated hybrid myotubes with their LIMB counterparts (Fig. S6).
For the engraftment study, donor SCs were isolated by ﬂow
cytometry based on Nestin-GFP expression (Figs. 1B and S3A) from
Nestin-GFP/MLC3F-nLacZ double transgenic mice. As detailed in
Materials and methods, the muscle-speciﬁc MLC3F-nLacZ trans-
gene drives β-gal expression in myoﬁber nuclei, providing a
histological means to trace contribution of differentiated progeny
of donor SCs based on X-gal staining. Additionally, both Nestin-
GFP and MLC3F-nLacZ transgenes were used here to quantify
donor contribution based on a genomic analysis (PCR on isolated
gDNA). To minimize engraftment variations due to potential
mouse to mouse differences, comparisons between EOM and LIMB
donor SCs were done within individual host mice, with EOM SCs
being injected into one TA muscle and LIMB SCs into the contral-
ateral TA muscle. For each independent experiment (n¼4), 3–4
host mice were engrafted with EOM and LIMB SCs populations
isolated from the same cohort of donor mice. Injected TAs were
harvested 3 weeks after transplantation and for each experiment
1–2 mice were processed for X-gal staining and the rest for
genomic analysis.
Inspection of X-gal staining in whole TAs demonstrated that
donor EOM SCs contributed nLacZþ myonuclei at a greater level
than LIMB SCs (Fig. 7B). The detection of the nuclear reporter
nLacZ in myonuclei upon donor cell engraftment is not necessarily
an exact reﬂection of the number of donor-derived nuclei as the
reporter protein, translated in the myoﬁber cytoplasm, may also
enter host myonuclei within neighboring domains of the same
myoﬁber (Kirillova et al., 2007; Yang et al., 1997). However, the
degree of MLC3F-nLacZ nuclei in donor muscle is certainly related
to the degree of engraftment and provides an efﬁcient qualitative
measure. Donor cell contribution was further quantiﬁed by geno-
mic analysis according to the donor-speciﬁc LacZ and GFP levels
each normalized to the level of two reference genes (Cyp1A1 and
H-ras), which permitted calculating the ratio between EOM and
LIMB engraftment per individual mice as detailed in Fig. 7C and D.
The majority of mice analyzed demonstrated a higher engraftment
of EOM SCs with EOM/LIMB engraftment ratios at 1.8–5.6 (n¼7),
while no mice harbored a signiﬁcant higher engraftment of LIMB
SCs. A pilot engraftment analysis of EOM vs. DIA SCs performed as
above also indicated a better efﬁciency of EOM SCs. This genomic
analysis detects donor contribution, regardless of whether cells
contributed to myoﬁber nuclei or just engrafted into the muscle
tissue. Hence, the use of both the histological and PCR approaches
has provided a more comprehensive insight into the engraftment
potential of each SC population, demonstrating altogether the
regenerative superiority of EOM SCs in terms of in-vivo engraft-
ment potency.
Concluding remarks
Our ﬁndings contribute novel insights into EOM SCs, focusing on
their in-situ signature, in-vitro expansion, and in-vivo engraftment
aptitude. To identify potential unique properties of EOM SCs, most
aspects were analyzed in comparison to SCs from the limb and
diaphragm muscles. We have shown that EOM SCs, regardless of
their distinctive Pax3-negative origin, display a common in-situ
molecular signature with their limb and diaphragm counterparts
(Pax7þ , Ki67 , Nestin-GFPþ , Myf5nLacZþ , MyoD-positive lineage
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origin). Further comparisons among the three muscle groups have
demonstrated that EOM SCs possess a superior expansion capacity,
contributing signiﬁcantly more proliferating and differentiating pro-
geny and impressively, many more renewal cells than their limb and
diaphragm counterparts. Interestingly, SCs of the masseter muscle
were also shown to have a larger proliferative and renewal potential
when compared clonally with EDL SCs (Ono et al., 2010). The
masseter is also of a Pax3-negative origin, but is classiﬁed within a
muscle group distinct from the EOMs (Harel et al., 2009). While the
masseter progenitors are derived from an Isl1-positive lineage (and
also show ancestral expression of Nkk2.5), the EOM progenitors are
not (Harel et al., 2009). Although it is tempting to consider the Pax3-
negative origin of SCs in both EOM and masseter as playing a role in
the expanded performance capacity of SCs from these muscles, a side
by side comparison of SCs from these two lineages is ﬁrst required.
Additionally, we showed that the robust growth and renewal proper-
ties of EOM SCs are maintained in preparations isolated from
dystrophin-null (mdx4cv) mice, while SCs from muscles affected by
dystrophin deﬁciency (i.e., limb and diaphragm) expand poorly in
cell culture assays. EOM SCs also retain higher performance in cell
transplantation assays in which donor cells were engrafted into host
mdx limb muscle.
Collectively, our study provides a comprehensive picture of
EOM myogenic progenitors, showing that while these cells share
common hallmarks with the prototypic SCs in somite-derived
muscles, they distinctively feature robust growth and renewal
capacities that warrant the title of high performance myo-engines
and promote consideration of their properties for developing new
approaches in cell-based therapy to combat skeletal muscle
wasting. Insights into the speciﬁc traits that underlie the EOM
SCs' robust performance can potentially establish new molecular
avenues for manipulating donor myogenic progenitors from the
easily accessible limb muscles. Furthermore, if proven relevant for
clinical use (i.e., expandable in vitro with resulting progeny
retaining high regenerative potency in vivo), human EOM SCs
could serve directly as an effective source for cell-based therapy.
Indeed, a protocol for retrieving human EOMs could ultimately be
developed based on the already existing Eye Bank programs,
allowing for the availability of a wide range of allotypes of human
donor EOM cells.
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